Editorial: Staging liver fibrosis in hepatitis C: A challenge for this decade

American Journal of Gastroenterology

Volumn 106, Issue 12, 2011, Pages 2121-2122

  Lai, Michelle ^a   Afdhal, Nezam H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ELASTOGRAPHY; HEPATITIS C; HEPATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PREDICTIVE VALUE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SEROLOGY; STAGING;

ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 82955201888     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.343     Document Type: Review

References (17)

1. Rizzo L et al. Comparison of transient elastography (TE) and acoustic radiation force impulse (ARFI) for non-invasive staging of liver fi brosis in patients with chronic hepatitis C. Am J Gastroenterol 2011;106:2112-20 (this issue).
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-51. (Pubitemid 351323895)
3. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20 (1 Pt 1): 15-20. (Pubitemid 24196485)
4. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fi brosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57. (Pubitemid 37466971)
5. Goldin RD, Goldin JG, Burt AD et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649-54. (Pubitemid 26373881)
6. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-8.
7. Manning DS, Afdhal NH. Diagnosis and quantitation of fi brosis. Gastroenterology 2008; 134: 1670-81.
8. Friedrich-Rust M, Ong MF, Martens S et al. Performance of transient elastography for the staging of liver fi brosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
9. Cohen EB, Afdhal NH. Ultrasound-based hepatic elastography: origins, limitations, and applications. J Clin Gastroenterol 2010; 44: 637-45.
10. Talwalkar JA, Yin M, Fidler JL et al. Magnetic resonance imaging of hepatic fi brosis: emerging clinical applications. Hepatology 2008; 47: 332-42. (Pubitemid 351171070)
11. Klibansky DA et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat 2011; advance online publication, 1 July 2011.
12. Pritchett S, Cardenas A, Manning D et al. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specifi c. J Viral Hepat 2011; 18: e75-80.
13. Goertz RS, Zopf Y, Jugl V et al. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fi brosis in viral hepatitis. Ultraschall Med 2010; 31: 151-5.
14. Sporea I, Sirli RL, Deleanu A et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med 2011; 32 (Suppl 1): S46-52.
15. Becker L, Salameh W, Sferruzza A et al. Validation of hepascore, compared with simple indices of fi brosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol 2009; 7: 696-701.
16. Jacobson IM, McHutchison JG, Dusheiko G et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364: 2405-16.
17. Poordad F, McCone J Jr, Bacon BR et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-206.